Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1988 1
1989 3
1990 6
1991 4
1992 5
1993 3
1994 5
1995 1
1996 3
1997 2
1998 13
1999 3
2000 3
2001 3
2002 3
2003 5
2004 7
2005 7
2006 8
2007 5
2008 3
2009 1
2010 4
2011 1
2012 2
2013 3
2014 6
2015 7
2016 5
2017 8
2018 4
2019 7
2020 2
2021 1
2022 1
2023 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.
Fleischmann R, Mysler E, Hall S, Kivitz AJ, Moots RJ, Luo Z, DeMasi R, Soma K, Zhang R, Takiya L, Tatulych S, Mojcik C, Krishnaswami S, Menon S, Smolen JS; ORAL Strategy investigators. Fleischmann R, et al. Among authors: demasi r. Lancet. 2017 Jul 29;390(10093):457-468. doi: 10.1016/S0140-6736(17)31618-5. Epub 2017 Jun 16. Lancet. 2017. PMID: 28629665 Clinical Trial.
Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study.
Wollenhaupt J, Lee EB, Curtis JR, Silverfield J, Terry K, Soma K, Mojcik C, DeMasi R, Strengholt S, Kwok K, Lazariciu I, Wang L, Cohen S. Wollenhaupt J, et al. Among authors: demasi r. Arthritis Res Ther. 2019 Apr 5;21(1):89. doi: 10.1186/s13075-019-1866-2. Arthritis Res Ther. 2019. PMID: 30953540 Free PMC article. Clinical Trial.
Heparin-induced thrombocytopenia.
Demasi R, Bode AP, Knupp C, Bogey W, Powell S. Demasi R, et al. Am Surg. 1994 Jan;60(1):26-9. Am Surg. 1994. PMID: 8273970 Review.
Impact of initial therapy with upadacitinib or adalimumab on achievement of 48-week treatment goals in patients with rheumatoid arthritis: post hoc analysis of SELECT-COMPARE.
Mysler E, Tanaka Y, Kavanaugh A, Aletaha D, Taylor PC, Song IH, Shaw T, Song Y, DeMasi R, Ali M, Fleischmann R. Mysler E, et al. Among authors: demasi r. Rheumatology (Oxford). 2023 May 2;62(5):1804-1813. doi: 10.1093/rheumatology/keac477. Rheumatology (Oxford). 2023. PMID: 36018230 Free PMC article. Clinical Trial.
Blunt injury of the abdominal aorta: a review.
Roth SM, Wheeler JR, Gregory RT, Gayle RG, Parent FN 3rd, Demasi R, Riblet J, Weireter LJ, Britt LD. Roth SM, et al. Among authors: demasi r. J Trauma. 1997 Apr;42(4):748-55. doi: 10.1097/00005373-199704000-00032. J Trauma. 1997. PMID: 9137272 Review.
What should nephrologists know about hand ischemia?
Asif A, Urbanes A, Scott EC, DeMasi RJ, Bourquelot P. Asif A, et al. Among authors: demasi rj. Semin Dial. 2007 Sep-Oct;20(5):465-74. doi: 10.1111/j.1525-139X.2007.00352.x. Semin Dial. 2007. PMID: 17897256 Review. No abstract available.
Advancing research and development of anti-infectives for children with a focus on antiretroviral therapy: A clinical development perspective.
Buchanan AM, Bekker A, Chandasana H, DeMasi R, Lulic Z, Ernest T, Brothers C, Min S, Ruel T, Tan LK. Buchanan AM, et al. Among authors: demasi r. Int J Antimicrob Agents. 2024 Oct;64(4):107306. doi: 10.1016/j.ijantimicag.2024.107306. Epub 2024 Aug 13. Int J Antimicrob Agents. 2024. PMID: 39146996 Free article. Review.
140 results